Notice of Annual General Meeting

Report this content

Copenhagen, Denmark, 11 March 2021 – Notice is hereby given of the annual general meeting of Curasight A/S (“Curasight” or the “Company”) to be held on:
Thursday, 25 March 2021 at 10:00 am CET

Due to the COVID-19 situation, the annual general meeting will be held as a completely electronic meeting without physical attendance. This is in accordance with Executive Order no. 2240 of 29 December 2020, which allows companies to conduct fully electronic general meetings even though this has not been approved in advance by the shareholders and stated in the Company’s Articles of Association. More information on how to participate in the annual general meeting can be found below in the section named “practical information”.

To the shareholders of Curasight A/S

The board of directors hereby convenes an ordinary general meeting of Curasight to be held on:

Thursday 25 March 2021 at 10:00 (CET) at the Company’s premises, Ole Maaløes Vej 3, room M4, DK-2200 Copenhagen N, Denmark.

The agenda for the general meeting is as follows:

  1. ELECTION OF CHAIRMAN OF THE MEETING
  2. REPORT ON THE ACTIVITIES OF THE COMPANY IN THE PAST FINANCIAL YEAR
  3. PRESENTATION OF THE ANNUAL REPORT WITH AUDITORS’ REPORT FOR ADOPTION
  4. RESOLUTION ON COVERING OF LOSSES IN ACCORDANCE WITH THE ADOPTED ANNUAL REPORT
  5. ELECTION OF MEMBERS TO THE BOARD OF DIRECTORS
  6. ELECTION OF AUDITOR
  7. PROPOSALS FROM THE BOARD OF DIRECTORS AND SHAREHOLDERS
  8. MISCELLANEOUS
 

Complete agenda:

Re 1:   Election of chairman of the meeting

The board of directors proposes that Per Falholt is elected as the chairman of the general meeting.

 Re 2:  Report on the activities of the Company in the past financial year

An oral report on the activities of the Company in the past financial year will be presented. The board of directors proposes that the report is noted by the general meeting.

Re 3:   Presentation of the annual report with auditors’ report for adoption

The board of directors proposes that the Company’s annual report with the auditors’ report for the financial year 2020 is adopted. The annual report is available on the Company’s website here.

Re 4:   Resolution on covering of losses in accordance with the adopted annual report

The board of directors proposes that the consolidated loss for the financial year 2020 of tDKK -5,552 is carried forward to the next financial year in accordance with the adopted annual report.

Re 5:   Election of members to the board of directors

The board of directors proposes re-election of the following members of the board of directors: Per Falholt, Lars Trolle, Charlotte Vedel, Andreas Kjær and Ulrich Krasilnikoff.

Re 6:   Election of auditor

The board of directors proposes re-election of PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab, CVR no. 39 29 64 38, as the Company’s auditor.

 Re 7:  Proposals from the board of directors and shareholders

No proposals have been received from the Board of Directors or the shareholders.

 

Practical information

Special circumstances due to COVID-19

Annual general meeting (without the possibility of physical attendance)

As mentioned above this years’ annual general meeting will be held without the possibility of physical attendance of the meeting due to the Covid-19 situation.Curasight will comply with the recommendations coming from the authorities due to COVID-19. The shareholders are encouraged to utilize the possibility to submit a proxy to the board of directors or vote by correspondence rather than exposing them-selves and others to unnecessary risks by opting for physical attendance.

 

Date of registration

A shareholder’s right to attend and vote at the annual general meeting is determined on the basis of the shares held by the shareholder on 18 March 2021 (date of registration). The shares held by each shareholder as at the date of registration are calculated on the basis of registration of the shareholder’s ownership in the register of shareholders (VP Securities) and notifications about ownership received by the company for entry into the register of shareholders in VP Securities, but which have not yet been registered in the register of shareholders.

 

Proxy

The shareholders may vote by proxy for the general meeting. A proxy and voting correspondence form can be find on the company’s website (www.curasight.com). Voting instructions by proxy shall be submitted by returning the proxy and voting by correspondence form, duly completed and signed, by email to uk@curasight.com. Proxies shall be submitted no later than 24 March 2021 at 4:00 pm CET.

 

Voting by Correspondence

Shareholders may – instead of voting in person at the general meeting – choose to vote by mail, i.e. voting in writing prior to the general meeting. A proxy and voting by correspondence form can be find on the company’s website (www.curasight.com). Any shareholder who wishes to vote by mail shall submit the proxy and voting by correspondence form, duly completed and signed, by email to uk@curasight.com. Votes delivered by mail must be submitted no later than 24 March 2021 at 4:00 pm CET and cannot be revoked.

 

Information:

To adopt the proposals under items 1, 3, 4, 5 og 6, a simple majority of the votes cast is required. 

For more information regarding Curasight, please contact:

Ulrich Krasilnikoff, CEO

Phone: +45 22 83 01 60

E-mail: uk@curasight.com

www.curasight.com



Curasight is a clinical development company based in Copenhagen, Denmark. The company is a pioneer in the field of exploiting a novel Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (“uPAR”). The technology is expected to improve diagnosis and risk stratification in multiple cancer types.

Subscribe

Documents & Links